[1] Novak P. Autonomic disorders[J]. Am J Med, 2019, 132:420-436.
[2] Mckeon A, Benarroch EE. Autoimmune autonomic disorders[J]. Handb Clin Neurol, 2016, 133:405-416.
[3] Li F, Meng LC, Shu JL, Sun YC, Lü H, Huang YN, Yuan Y. The eightieth case:young women, sitting and standing intolerance with vomiting after eating and body sweating for two months[J]. Zhonghua Shen Jing Ke Za Zhi, 2018, 51:831-835.[李凡, 孟令超, 舒俊龙, 孙云闯, 吕鹤, 黄一宁, 袁云. 第80例——青年女性,坐立不耐受伴进食后呕吐和躯体无汗2个月余[J]. 中华神经科杂志, 2018, 51:831-835.]
[4] Koike H, Atsuta N, Adachi H, Iijima M, Katsuno M, Yasuda T, Fukada Y, Yasui K, Nakashima K, Horiuchi M, Shiomi K, Fukui K, Takashima S, Morita Y, Kuniyoshi K, Hasegawa Y, Toribe Y, Kajiura M, Takeshita S, Mukai E, Sobue G. Clinicopathological features of acute autonomic and sensory neuropathy[J]. Brain, 2010, 133:2881-2896.
[5] Koike H, Hirohisa W, Sobue G. The spectrum of immune-mediated autonomic neuropathies:insights from the clinicopathological features[J]. J Neurosurg Psychiatry, 2013, 84:98-106.
[6] Young RR, Asbury AK, Adams RD, Corbett JL. Pure pan-dysautonomia with recovery[J]. Trans Am Neurol Assoc, 1969, 94:355-357.
[7] Wijdicks EF, Klein CJ. Guillain-Barré syndrome[J]. Mayo Clin Proc, 2017, 92:467-479.
[8] Leonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR, van Doorn PA, Dourado ME, Hughes RA, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain-Barré syndrome in ten steps[J]. Nat Rev Neurol, 2019, 15:671-683.
[9] Bölükba? i F, Ersen G, Gündüz A, Karaali-Savrun F, Yazici S, Uzun N, Akalin MA, Kiziltan ME. Guillain-Barré syndrome and its variants:clinical course and prognostic factors[J]. Noro Psikiyatr Ars, 2019, 56:71-74.
[10] Neurology Branch, Chinese Medical Association; Peripheral Neuropathy Cooperative Group, Neurology Branch, Chinese Medical Association; Electromyography and Clinical Neuroelectrophysiology Group, Neurology Branch, Chinese Medical Association; Neuromyopathology Group, Neurology Branch, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of Guillain-Barré syndrome[J]. Zhonghua Shen Jing Ke Za Zhi, 2019, 52:877-882.[中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组,中华医学会神经病学分会肌电图与临床神经电生理学组, 中华医学会神经病学分会神经肌肉病学组. 中国吉兰-巴雷综合征诊治指南2019[J]. 中华神经科杂志, 2019, 52:877-882.]
[11] Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionicacetylcholine receptors in autoimmune autonomic neuropathies[J]. N Engl J Med, 2000, 343:847-855.
[12] Golden EP, Vernino S. Autoimmune autonomic neuropathies and ganglionopathies:epidemiology, pathophysiology, and therapeutic advances[J]. Clin Auton Res, 2019, 29:277-288.
[13] Nakane S, Mukaino A, Higuchi O, Watari M, Maeda Y, Yamakawa M, Nakahara K, Takamatsu K, Matsuo H, Ando Y. Autoimmune autonomic ganglionopathy:an update on diagnosis and treatment[J]. Expert Rev Neurother, 2018, 18:953-965.
[14] Nakane S, Watari M, Ando Y. Anti-ganglionic acetylcholine receptor antibodies, autoimmune autonomic ganglionopathy, and related disorders[J]. Brain Nerve, 2018, 70:383-393.
[15] Goodman BP, Crepeau A, Dhawan PS, Khoury JA, Harris LA. Spectrum of autonomic nervous system impairment in Sjögren Syndrome[J]. Neurologist, 2017, 22:127-130.
[16] Pavlakis PP, Alexopoulos H, Kosmidis ML, Stamboulis E, Routsias JG, Tzartos SJ, Tzioufas AG. Peripheral neuropathies in Sjögren syndrome:a new reappraisal[J]. J Neurol Neurosurg Psychiatry, 2011, 82:798-802.
[17] Nakane S, Mukaino A, Maeda Y, Higuchi O, Matsuo H, Ando Y. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy:a Japanese survey[J]. J Neurol Neurosurg Psychiatry, 2017, 88:367-368.
[18] Mukaino A, Nakane S, Higuchi O, Nakamura H, Miyagi T, Shiroma K, Tokashiki T, Fuseya Y, Ochi K, Umeda M,Nakazato T, Akioka S, Maruoka H, Hayashi M, Igarashi S, Yokoi K, Maeda Y, Sakai W, Matsuo H, Kawakami A. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome[J]. Mod Rheumatol, 2016, 26:708-715.
[19] Winston N, Vernino S. Recent advances in autoimmune autonomic ganglionopathy[J]. Curr Opin Neurol, 2010, 23:514-518.
[20] Imrich R, Vernino S, Eldadah BA, Holmes C, Goldstein DS. Autoimmune autonomic ganglionopathy:treatment by plasma exchanges and rituximab[J]. Clin Auton Res, 2009, 19:259-262.
[21] Cheshire WP. Chemical pharmacotherapy for the treatment of orthostatic hypotension[J]. Expert Opin Pharmacother, 2019, 20:187-199.
[22] Byun JI, Moon J, Kim DY, Shin H, Sunwoo JS, Lim JA, Kim TJ, Lee WJ, Lee HS, Jun JS, Park KI, Lee ST, Jung KH, Jung KY, Lee SK, Chu K. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension[J]. Neurology, 2017, 89:1078-1086. |